Vanguard Group Inc Bio Xcel Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,187,466 shares of BTAI stock, worth $2.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,187,466

Previous 1,201,377 1.16%

Holding current value

$2.77 Million

Previous $732,000 40.03%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$0.32 - $0.73 $4,451 - $10,155	-13,911 Reduced 1.16%	1,187,466 $439,000
Q3 2024 Nov 13, 2024	BUY	$0.53 - $1.34 $122,401 - $309,468	230,947 Added 23.8%	1,201,377 $732,000
Q2 2024 Aug 13, 2024	SELL	$1.14 - $2.97 $146,997 - $382,966	-128,945 Reduced 11.73%	970,430 $1.24 Million
Q1 2024 May 10, 2024	BUY	$1.95 - $4.04 $19,328 - $40,044	9,912 Added 0.91%	1,099,375 $3.1 Million
Q4 2023 Feb 14, 2024	SELL	$2.32 - $5.51 $304,075 - $722,179	-131,067 Reduced 10.74%	1,089,463 $3.21 Million
Q3 2023 Nov 14, 2023	BUY	$2.49 - $11.85 $228,601 - $1.09 Million	91,808 Added 8.13%	1,220,530 $3.09 Million
Q2 2023 Aug 14, 2023	BUY	$6.39 - $28.58 $413,739 - $1.85 Million	64,748 Added 6.09%	1,128,722 $7.52 Million
Q1 2023 May 15, 2023	BUY	$17.7 - $33.24 $349,929 - $657,154	19,770 Added 1.89%	1,063,974 $19.9 Million
Q4 2022 Feb 10, 2023	BUY	$10.25 - $22.43 $143,838 - $314,760	14,033 Added 1.36%	1,044,204 $22.4 Million
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $387,543 - $619,584	34,633 Added 3.48%	1,030,171 $12.2 Million
Q2 2022 Aug 12, 2022	SELL	$9.03 - $21.55 $577,892 - $1.38 Million	-63,997 Reduced 6.04%	995,538 $13.1 Million
Q1 2022 May 13, 2022	BUY	$15.0 - $22.83 $558,060 - $849,367	37,204 Added 3.64%	1,059,535 $22.2 Million
Q4 2021 Feb 14, 2022	BUY	$20.12 - $35.09 $1.09 Million - $1.91 Million	54,411 Added 5.62%	1,022,331 $20.8 Million
Q3 2021 Nov 12, 2021	BUY	$23.84 - $32.03 $1.56 Million - $2.09 Million	65,274 Added 7.23%	967,920 $29.4 Million
Q2 2021 Aug 13, 2021	BUY	$29.06 - $38.83 $26.2 Million - $35 Million	902,646 New	902,646 $26.2 Million

Others Institutions Holding BTAI

# of Institutions

Shares Held

8.63M

Call Options Held

34.5K

Put Options Held

59.4K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $65.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Bio Xcel Therapeutics, Inc. Transaction History